National Blood Sector Research and Development Program – Round 3

Overview

The National Blood Sector Research and Development Program forms an important component of the National Blood Authority’s blood sector research and development framework and aims to facilitate world-class research and development in Australia that contributes to optimising the use, management and administration of blood products, and improve patient outcomes.  The Program is focussed on research areas that have been identified by pre-existing strategic programs of the National Blood Authority and governments in the blood sector. They are:   Patient Blood Management  evidence gaps, as identified in the National Blood Authority’s Patient Blood Management Guidelines, and efficient and effective use of immunoglobulin products, as highlighted through the Immunoglobulin Governance Program.  A total of $1.275 million is available under Round 3 of the National Blood Sector Research and Development Program for single year or multiple year projects.   Grants are offered under three categories as outlined below:  Project Grants, typically $30,000 to $150,000 per year to be expended over a period of up to three years. Applications should be for an entire, discrete research project proposal.  Seed Grants, typically under $50,000 to be expended over one year.  Applications for seed funding should be for early stages of innovative new research, or for effort generation of preliminary data needed to support future grant applications.  Scholarships, typically $25,000 to $30,000 to be expended over one year.  Scholarship grants are intended to support medical researchers in the attainment of a PhD or Master’s degree or postdoctoral research fellow research.  Application forms are available on the National Blood Authority Website at   https://www.blood.gov.au/research-and-development